MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
about
Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with DoxorubicinNon-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinomaThe Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.Epigenetic alternations and cancer chemotherapy response.MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340/XIAP signaling pathway.Increased expression of miR-155 and miR-222 is associated with lymph node positive status.Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.
P2860
Q35926350-18CB5926-16C0-487F-89EC-C32E4DC486DBQ37151107-2F6D2AAF-531B-4398-BA5C-C16C50DF4F15Q37210093-D4AEEF00-126B-48E0-BF4A-AECDD0A8BE9AQ38432397-CBBD50A9-3D9F-45DC-9C4C-DA9E8A3DCC9BQ38680431-A89DE745-BEC9-4D4B-A4B3-126466C02BD0Q38830661-EA9F345C-1513-4190-99B2-2DCBE2486E6CQ41143470-6DAC326C-7760-4B3D-A7D0-D92E3BBD0E30Q47112669-91C1B0CC-9036-4820-8721-9C380E0DC900Q48239512-69629CAF-4758-477D-A075-B7F8FB66F2DC
P2860
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
@en
type
label
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
@en
prefLabel
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
@en
P2093
P2860
P50
P356
P1476
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
@en
P2093
Alba Guijarro
Begoña Pineda
Eduardo Tormo
Jaume Fores
Joan Climent
Pilar Eroles
P2860
P304
P356
10.1002/JCB.25162
P577
2015-03-19T00:00:00Z